Serum magnesium: A biomarker of cardiovascular risk revisited?

Magnesium Research

Volumn 25, Issue 2, 2012, Pages 49-53

  del Gobbo, Liana C ^a   Elin, Ronald J ^b   Poirier, Paul ^c   Egeland, Grace M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b University of Louisville School of Medicine   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM; OMEGA 3 FATTY ACID;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG DOSE COMPARISON; EVIDENCE BASED DENTISTRY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAGNESIUM BLOOD LEVEL; MORTALITY; PHYSICAL ACTIVITY; RISK ASSESSMENT; RISK REDUCTION; SUDDEN DEATH;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIET; HUMANS; MAGNESIUM; REFERENCE VALUES; RISK FACTORS;

EID: 84864079327     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2012.0309     Document Type: Article

References (38)

1. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 2000; 294: 1-26.
2. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999; 83: 302-20.
3. Abbot LG & Rude RK. Clinical manifestations of magnesium deficiency. Miner Electrol Metab 1993; 19: 314-22.
4. Parikka H, Toivonen L, Naukkarinen V, Tierala I, Pohjola-Sintonen S, Heikkilä J, Nieminen MS. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J 1999; 20: 111-20.
5. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: A review. Mol Cell Biochem 2002; 238: 163-79.
6. Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L. Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post-menopausal women. J Am Coll Nutr 2007; 26: 121-32.
7. Klevay LM & Milne DB. Low dietary magnesium increases supraventricular ectopy. Am J Clin Nutr 2002; 75: 550-4.
8. Wallach S. Effects of magnesium on skeletal metabolism. Magnesium Trace Elem 1990; 9: 1-14.
9. Webster PO. Magnesium. Am J Clin Nutr 1987; 45: 1305-12.
10. Arnaud MJ. Update on the assessment of magnesium status. Br J Nutr 2008; 99: S24-S36.
11. Sabatier M, Grandvuillemin A, Kastenmayer P, Aeschlimana J, Bouisset F, Arnaud MJ, Dumoulin G, Berthelot A. Influence of the consumption pattern of magnesium from magnesium-rich mineral water on magnesium bioavailability. Br J Nutr 2011; 106: 331-4.
12. Dimeski G, Badrick T, St John A. Ion Selective Electrodes (ISEs) and interferences-A review. Clin Chim Acta 2010; 411: 309-17.
13. Institute of Medicine (IOM). Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vita-min D, and Fluoride. Washington, DC: National Academies Press, 1997; 202-3.
14. Lowenstein FW & Stanton MF. Serum magnesium levels in the United States, 1971-1974. J Am Coll Nutr 1986; 5: 399-414.
15. Elin RJ. Assessment of magnesium status. Clin Chem 1987; 33: 1965-70.
16. Elin RJ. Re-evaluation of the concept of chronic, latent magnesium deficiency. Magnes Res 2011; 24: 225-7.
17. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin and carotid arterial-wall thickness the ARIC study. J Clin Epidemiol 1995; 48: 927-40.
18. Chiuve SE, Korngold EC, Januzzi JL, Gantzer ML, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 2011; 93: 253-60.
19. Del Gobbo LC, Song Y, Elin RJ, Meltzer SJ, Egeland GM. Gestational glucose intolerance modifies the association between magnesium and glycemic variables in mothers and daughters 15 years post-partum. Magnes Res 2012; 25(2).
20. Shils ME. Magnesium in Health and Disease. Annu Rev Nutr 1988; 8: 429-60.
21. Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2010; 160: 464-70.
22. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998; 136: 480-90.
23. Chacko SA, Sul J, Song YQ, Li X, LeBlanc J, You Y, Butch A, Liu S. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in over weight individuals. Am J Clin Nutr 2011; 93: 463-73.
24. Hadjistavri LS, Sarafidis PA, Georgianos PI, Tziolas IM, Aroditis CP, Hitoglou-Makedou A, Zebekakis PE, Pikilidou MI, Lasaridis AN. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit 2010; 16: CR307-CR312.
25. Mooren FC, Kruger K, Volker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab 2011; 13: 281-4.
26. Witkowski M, Hubert J, Mazur A. Methods of assessment of magnesium status in humans: a systematic review. Magnesium Res 2011; 24: 163-80.
27. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabetic Med 2006; 23: 1050-6.
28. Kelepouris E, Agus ZS. Hypomagnesemia: renal magnesium handling. Semin Nephrol 1998; 18: 58-73.
29. Rylander R, Mégevand Y, Lasserre B, Amstutz W, Granbom S. Moderate alcohol consumption and urinary excretion of magnesium and calcium. Scand J Clin Lab Inv 2001; 61: 401-5.
30. Sarafidis PA, Georgianos PI, Lasaridis AN. Diuretics in clinical practice. Part II: electrolyte and acid base disorders complicating diuretic therapy. Expert Opin Drug Saf 2010; 9: 259-73.
31. Khan AM, Sullivan L, McCabe E, Levy D, Vasan RS, Wang TJ. Lack of association between serum magnesium and the risks of hypertension and car diovascular disease. Am Heart J 2010; 160: 715-20.
32. Hashimoto T, Hara A, Ohkubo T, Kikuya M, Shintani Y, Metoki H, Inoue R, Asayama K, Kanno A, Nakashita M, Terata S, Obara T, Hirose T, Hoshi H, Totsune K, Satoh H, Imai Y. Serum magnesium, ambulatory blood pressure, and carotid artery alteration: the Ohasama study. Am J Hypertens 2010; 23: 1292-8.
33. Tsuji H, Venditti FJ, Evans JC, Larson MG, Levy D. The associations of levels of serum potassium and magnesium with ventricular premature complexes (The Framingham Heart Study). Am J Cardiol 1994; 74: 232-5.
34. Del Gobbo LC, Song Y, Poirier P, Dewailly E, Elin RJ, Egeland GM. Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes. Cardiovasc Diabetol 2012; 11(1): 23.
35. Reffelmann T, Dorr M, Ittermann T, Schwahn C, Völzke H, Ruppert J, Robinson D, Felix SB. Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors. Atherosclerosis 2010; 213: 563-9.
36. Reffelmann T, Ittermann T, Dörr M, Völzke H, Reinthaler M, Petersmann A, Felix SB. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis 2011; 219: 280-4.
37. Ford ES. Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol 1999; 28: 645-651.
38. Elin RJ. Assessment of magnesium status for diag nosis and therapy. Magnes Res 2010; 23: S194-S198.